Updated Jul 16, 2026
Berman David M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $5.01M.

David M. Berman is the Head of R&D at Immunocore Holdings plc, a biotechnology company focused on developing therapies for oncology and infectious diseases. He has been involved in multiple SEC filings related to his role but has not made any reported stock transactions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-19 | IMCR | Immunocore Holdings plc | S — Open-market sale | 6.0K | $32.35 | $193K |
| 2026-02-19 | IMCR | Immunocore Holdings plc | M — Option exercise | 11.8K | $0.00 | |
| 2025-09-30 | IMCR | Immunocore Holdings plc | S — Open-market sale | 61.8K | $35.23 | $2.18M |
| 2025-09-30 | IMCR | Immunocore Holdings plc | M — Option exercise | 61.8K | $17.46 | $1.08M |
| 2025-09-12 | IMCR | Immunocore Holdings plc | S — Open-market sale | 200 | $35.01 | $7K |
| 2025-09-12 | IMCR | Immunocore Holdings plc | M — Option exercise | 200 | $17.46 | $3K |
| 2025-09-12 | IMCR | Immunocore Holdings plc | S — Open-market sale | 1.3K | $36.31 | $47K |
| 2025-09-12 | IMCR | Immunocore Holdings plc | S — Open-market sale | 21.2K | $35.63 | $756K |
| 2025-09-12 | IMCR | Immunocore Holdings plc | M — Option exercise | 22.5K | $17.46 | $393K |
| 2025-09-10 | IMCR | Immunocore Holdings plc | S — Open-market sale | 19.1K | $36.28 | $692K |
| 2025-09-10 | IMCR | Immunocore Holdings plc | M — Option exercise | 19.1K | $17.46 | $333K |
| 2025-09-10 | IMCR | Immunocore Holdings plc | S — Open-market sale | 1.2K | $36.77 | $44K |
| 2025-09-10 | IMCR | Immunocore Holdings plc | S — Open-market sale | 30.1K | $36.12 | $1.09M |
| 2025-09-10 | IMCR | Immunocore Holdings plc | M — Option exercise | 31.3K | $17.46 | $547K |
David M. Berman is the Head of R&D at Immunocore Holdings plc, a biotechnology company focused on developing therapies for oncology and infectious diseases. He has been involved in multiple SEC filings related to his role but has not made any reported stock transactions.…
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($5.01M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Berman David M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.